Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Atria A ATRAV Apr 9, 2021 12.42 +1.64   
 Basware BAS1V Apr 9, 2021 37.75 -2.83   
 BBS-Bioactive Bone Substitutes BONEH Apr 9, 2021 3.46 +0.29   
 Bilot Plc BILOT Apr 9, 2021 7.52 -0.27   
 Biohit B BIOBV Apr 9, 2021 2.17 +0.93   
 Bittium BITTI Apr 9, 2021 6.73 +1.05   
 Boreo Oyj BOREO Apr 9, 2021 49.80 -0.80   
 CapMan CAPMAN Apr 9, 2021 2.68 +0.37   
 Cargotec CGCBV Apr 9, 2021 45.66 -1.42   
 Caverion CAV1V Apr 9, 2021 5.33 +0.19   
 Citycon CTY1S Apr 9, 2021 7.38 0.00   
 Componenta CTH1V Apr 9, 2021 3.80 -1.35   
 Consti Plc CONSTI Apr 9, 2021 13.50 0.00   
 Detection Technology DETEC Apr 9, 2021 26.50 +3.11   
 Digia DIGIA Apr 9, 2021 8.10 +2.53   
 Digitalist Group DIGIGR Apr 9, 2021 0.05 +0.41   
 Dovre Group DOV1V Apr 9, 2021 0.40 -3.39   
 EAB Group EAB Apr 9, 2021 3.64 -0.82   
 Eezy Oyj EEZY Apr 9, 2021 5.54 +2.21   
 Efecte PLC EFECTE Apr 9, 2021 14.70 +1.38   
 Elecster A ELEAV Apr 9, 2021 10.35 +2.48   
 Elisa ELISA Apr 9, 2021 49.38 -0.42   
 Endomines ENDOM Apr 9, 2021 0.28 -0.70   
 Enedo ENEDO Apr 9, 2021 0.48 +13.78   
 Enento Group ENENTO Apr 9, 2021 35.50 0.00   
 eQ EQV1V Apr 9, 2021 19.12 +1.06   
 Ericsson B ERIBR Apr 9, 2021 11.86 +1.42   
 Etteplan ETTE Apr 9, 2021 16.20 +1.50   
 Evli Pankki EVLI Apr 9, 2021 16.95 +0.59   
 Exel Composites EXL1V Apr 9, 2021 9.00 -1.53   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK